If you need more lookups,
subscriptions start at $34 USD/month.
Simon McCarthy Location
Portland, OR, US
Simon McCarthy Work
2016 -now Chief Scientific Officer @
2015 -2016 Science and Technology Fellow @ Hemcon Medical Technologies
2003 -2015 Chief Scientist @ Hemcon Medical Technologies
2000 -2003 Senior Scientist @
1989 -1999 Scientist @
Simon McCarthy Education
Monash University
PhD (Physical & Polymer Chemistry)
1981-1988
Monash University
BS (Mathematics, Computer Science & Chemistry, Majoring in Chemistry)
1977-1980
Simon McCarthy Skills
Strategy
Fluorescence Microscopy
Leadership
Microscopy
Cell Culture
Medical Devices
In Vitro
GPC
Research and Development R&d
u.s. Food and Drug Administration Fda
Biotechnology
V&V
Technology
Program Management
Biomedical Engineering
ISO 13485
FTIR
Biochemistry
Technology Transfer
Molecular Biology
Project Management
Assay Development
Cell Biology
Cell
FDA
Surgery
Lifesciences
Tissue Engineering
Commercialization
Drug Delivery
Biomaterials
Laser
CAPA
Immunology
R&d
Hemostasis
Biocompatibility
Design Control
Cellulose
Validation
Verification and Validation V&V
Characterization
UV/Vis
Organic Chemistry
Microbiology
Life Sciences
Polymers
Corrective and Preventive Action Capa
GMP
Biodegradation
UV/Vis Spectroscopy
ELISA
Microsoft Excel
Research and Development
u.s. Food and Drug Administration
Corrective and Preventive Action
Verification and Validation
Simon McCarthy Summary
Simon McCarthy, based in Portland, OR, US, is currently a Chief Scientific Officer at Tricol Biomedical, Inc.. Simon McCarthy brings experience from previous roles at Hemcon Medical Technologies, Oregon Medical Laser Center and CSIRO Division of Chemicals and Polymers. Simon McCarthy holds a 1981 - 1988 PhD in Physical & Polymer Chemistry @ Monash University. With a robust skill set that includes Strategy, Fluorescence Microscopy, Leadership, Microscopy, Cell Culture and more. Simon McCarthy has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Simon McCarthy?
Find contact details for 700 million professionals.